Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Signorelli

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Acta Bio-Medica : Atenei Parmensis|November 5, 2021
COVID-19 second wave: appropriateness of admissions to the Emergency Department of a main metropolitan hospital in MilanEleonora Bossi, Vincenza Gianfredi, Anna Odone, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 2, 2017
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populationsMarco Vinceti, Carlotta Malagoli, Sara Fabbi, et al.
Cancers|October 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA StudyCarlo Signorelli, Michele Basso, Maria Alessandra Calegari, et al.
Cancers|June 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA StudyCarlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA StudyCarlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2020
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, ItalyFabio Ciceri, Antonella Castagna, Patrizia Rovere-Querini, et al.
Acta Bio-Medica : Atenei Parmensis|July 1, 2022
COVID-19: opinions and behavior of Italian general population during the first epidemic phaseCristina Genovese, Vincenza La Fauci, Angela Di Pietro, et al.
Human Vaccines & Immunotherapeutics|March 8, 2014
Influenza vaccination coverage among medical residents: an Italian multicenter surveyClaudio Costantino, Walter Mazzucco, Elena Azzolini, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST StudyAugusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Acta Bio-Medica : Atenei Parmensis|November 5, 2021
COVID-19 second wave: appropriateness of admissions to the Emergency Department of a main metropolitan hospital in MilanEleonora Bossi, Vincenza Gianfredi, Anna Odone, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 2, 2017
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populationsMarco Vinceti, Carlotta Malagoli, Sara Fabbi, et al.
Cancers|October 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA StudyCarlo Signorelli, Michele Basso, Maria Alessandra Calegari, et al.
Cancers|June 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA StudyCarlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA StudyCarlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2020
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, ItalyFabio Ciceri, Antonella Castagna, Patrizia Rovere-Querini, et al.
Acta Bio-Medica : Atenei Parmensis|July 1, 2022
COVID-19: opinions and behavior of Italian general population during the first epidemic phaseCristina Genovese, Vincenza La Fauci, Angela Di Pietro, et al.
Human Vaccines & Immunotherapeutics|March 8, 2014
Influenza vaccination coverage among medical residents: an Italian multicenter surveyClaudio Costantino, Walter Mazzucco, Elena Azzolini, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST StudyAugusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Pageof 30